Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETOPOSIDE vs MITOXANTRONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ETOPOSIDE vs MITOXANTRONE: Safety Overview

Metric ETOPOSIDE MITOXANTRONE
Total FAERS Reports 52,603 4,166
Deaths Reported 11,780 995
Death Rate 22.4% 23.9%
Hospitalizations 17,699 1,556
Average Patient Age 42.5 yrs 37.0 yrs
% Female Patients 41.8% 48.0%
FDA Approval Date Aug 30, 1995 Apr 11, 2006
Manufacturer Avyxa Pharma, LLC Meitheal Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued